Free Trial

InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume

InMed Pharmaceuticals logo
$2.72 +0.05 (+1.87%)
Closing price 04/17/2025 03:56 PM Eastern
Extended Trading
$2.65 -0.07 (-2.57%)
As of 04/17/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InMed Pharmaceuticals Short Interest Data

InMed Pharmaceuticals (INM) has a short interest of 27,500 shares, representing 3.87% of the float (the number of shares available for trading by the public). This marks a 26.73% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 230,369 shares to cover all short positions.

Current Short Interest
27,500 shares
Previous Short Interest
21,700 shares
Change Vs. Previous Month
+26.73%
Dollar Volume Sold Short
$56,925.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
1,207,000 shares
Short Percent of Float
3.87%
Today's Trading Volume
7,145 shares
Average Trading Volume
230,369 shares
Today's Volume Vs. Average
3%
Short Selling InMed Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INM Short Interest Over Time

INM Days to Cover Over Time

INM Percentage of Float Shorted Over Time

InMed Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202527,500 shares $56,925.00 +26.7%3.9%0.1 $2.07
3/15/202521,700 shares $61,194.00 -19.3%3.1%0 $2.82
2/28/202526,900 shares $79,086.00 -25.1%3.8%0.1 $2.94
2/15/202535,900 shares $113,444.00 +8.5%5.0%0.1 $3.16
1/31/202533,100 shares $101,948.00 +1,125.9%N/A0.1 $3.08
1/15/20252,700 shares $11,718.00 -71.0%N/A0 $4.34
12/31/20249,300 shares $44,082.00 -30.1%N/A0.2 $4.74
12/15/202413,300 shares $69,958.00 +3.9%N/A0.3 $5.26
11/30/202412,800 shares $54,912.00 -50.6%N/A0.3 $4.29
11/15/202425,900 shares $110,852.00 -77.6%N/A0.5 $4.28
10/31/2024115,500 shares $30,711.45 +188.8%N/A0 $0.27
10/15/202440,000 shares $8,760.00 -57.1%N/A0 $0.22
9/30/202493,200 shares $22,088.40 -82.6%N/A0 $0.24
9/15/2024534,900 shares $139,822.86 +55.3%N/A0.1 $0.26
8/31/2024344,500 shares $122,263.05 +818.7%N/A0 $0.35
8/15/202437,500 shares $5,400.00 -85.2%N/A0 $0.14
7/31/2024253,200 shares $44,512.56 +85.2%N/A0.2 $0.18
7/15/2024136,700 shares $36,457.89 +61.4%N/A0.1 $0.27
6/30/202484,700 shares $22,487.85 -43.5%N/A0.1 $0.27
6/15/2024150,000 shares $34,005.00 +252.9%N/A0.2 $0.23
5/31/202442,500 shares $12,537.50 -44.6%N/A0.1 $0.30
5/15/202476,700 shares $21,015.34 -78.6%N/A0.2 $0.27
4/30/2024359,000 shares $96,571.00 +213.5%N/A0.9 $0.27
4/15/2024114,500 shares $36,491.15 +1,011.7%N/A0.3 $0.32
3/31/202410,300 shares $3,749.20 -81.9%N/A0 $0.36
3/15/202457,000 shares $20,520.00 -13.9%N/A0.3 $0.36
2/29/202466,200 shares $27,473.00 -52.1%N/A0.3 $0.42
2/15/2024138,300 shares $47,990.10 +244.9%N/A0.7 $0.35
1/31/202440,100 shares $14,431.99 -43.4%N/A0.2 $0.36
1/15/202470,800 shares $27,081.00 -47.2%N/A0 $0.38
12/31/2023134,000 shares $55,744.00 +1,213.7%N/A0.1 $0.42
12/15/202310,200 shares $3,672.00 -65.9%N/A0 $0.36
11/30/202329,900 shares $13,156.00 +510.2%N/A0 $0.44
11/15/20234,900 shares $1,989.40 -74.1%N/A0 $0.41
10/31/202318,900 shares $9,143.82 +339.5%N/A0 $0.48
10/15/20234,300 shares $2,743.40 +377.8%N/A0 $0.64
9/30/2023900 shares $629.91 -90.1%N/A0 $0.70
9/15/20239,100 shares $7,683.13 -65.4%N/A0.2 $0.84
8/31/202326,300 shares $21,592.30 +64.4%N/A0.5 $0.82
8/15/202316,000 shares $14,961.60 -61.5%N/A0.2 $0.94
The Crypto Market is About to Change Lives (Ad)

I've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free.

Claim your FREE copy of my controversial book before I change my mind.
7/31/202341,500 shares $46,480.00 +112.8%N/A0.5 $1.12
7/15/202319,500 shares $18,721.95 +2.6%N/A0.2 $0.96
6/30/202319,000 shares $17,480.00 -63.2%N/A0.2 $0.92
6/15/202351,600 shares $65,532.00 +4.7%N/A0.4 $1.27
5/31/202349,300 shares $66,062.00 -24.0%N/A0.1 $1.34
5/15/202364,900 shares $75,284.00 -30.8%N/A0.1 $1.16
4/30/202393,800 shares $112,560.00 -25.7%N/A0.2 $1.20
4/15/2023126,300 shares $157,875.00 +3.8%N/A0.2 $1.25
3/31/2023121,700 shares $131,436.00 -27.7%N/A0.2 $1.08
3/15/2023168,400 shares $178,504.00 +194.9%N/A0.2 $1.06
2/28/202357,100 shares $75,943.00 -15.8%N/A0.1 $1.33
2/15/202367,800 shares $113,226.00 -7.6%N/A0.1 $1.67
1/31/202373,400 shares $135,056.00 -75.4%N/A0.1 $1.84
1/15/2023297,800 shares $562,842.00 +443.4%3.8%0.3 $1.89
12/30/202254,800 shares $110,696.00 +13.0%0.7%0.1 $2.02
12/15/202248,500 shares $90,210.00 +62.8%0.6%0.1 $1.86
11/30/202229,800 shares $78,970.00 +223.9%0.4%0 $2.65
11/15/20229,200 shares $25,576.00 -32.9%0.1%0 $2.78
10/31/202213,700 shares $41,785.00 +121.0%0.2%0 $3.05
10/15/20226,200 shares $32,922.00 -83.9%0.1%0 $5.31
9/30/202238,600 shares $254,516.82 -57.3%0.5%0 $6.59
9/15/202290,300 shares $867,783.00 +12,800.0%1.2%0.1 $9.61
8/31/2022700 shares $4,165.00 -89.4%N/A0 $5.95
8/15/20226,600 shares $2,571.36 -62.5%0.1%0 $0.39
7/31/202217,600 shares $6,864.00 -18.9%0.2%0.1 $0.39
7/15/202221,700 shares $8,029.00 +6.4%0.3%0.1 $0.37
6/30/202220,400 shares $9,596.16 -80.1%0.3%0.1 $0.47
6/15/2022102,300 shares $53,400.60 +47.6%1.3%0.5 $0.52
5/31/202269,300 shares $53,361.00 -29.4%0.9%0.3 $0.77
5/15/202298,100 shares $81,423.00 -34.3%1.3%0.5 $0.83
4/30/2022149,300 shares $135,863.00 -8.7%1.9%0.7 $0.91
4/15/2022163,600 shares $142,806.44 +34.1%2.1%0.8 $0.87
3/31/2022122,000 shares $115,009.40 +114.4%1.6%0.9 $0.94
3/15/202256,900 shares $41,024.90 -35.3%0.7%0.6 $0.72
2/28/202287,900 shares $82,819.38 +2.6%1.1%0.8 $0.94
2/15/202285,700 shares $99,412.00 -2.7%1.1%0.3 $1.16
1/31/202288,100 shares $106,601.00 -15.7%1.1%0 $1.21
1/15/2022104,500 shares $129,580.00 +74.5%1.3%0 $1.24
12/31/202159,900 shares $78,469.00 -8.4%0.8%0 $1.31
12/15/202165,400 shares $96,792.00 -56.5%0.8%0 $1.48
11/30/2021150,400 shares $285,760.00 +69.9%1.9%0.1 $1.90
11/15/202188,500 shares $118,590.00 -19.7%1.1%0 $1.34
10/29/2021110,200 shares $168,055.00 +69.3%1.4%0.2 $1.53
10/15/202165,100 shares $91,140.00 -2.5%0.8%0.1 $1.40
9/30/202166,800 shares $116,900.00 +189.2%0.8%0.3 $1.75
9/15/202123,100 shares $47,553.66 +216.4%0.3%0.2 $2.06
8/31/20217,300 shares $16,133.00 -92.4%0.1%0.1 $2.21
8/13/202196,600 shares $231,840.00 -47.8%1.2%1.4 $2.40
7/30/2021185,100 shares $516,429.00 +98.2%2.3%2.6 $2.79
7/15/202193,400 shares $249,378.00 +396.8%1.2%1.3 $2.67
Trump’s Secret Weapon (Ad)

Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.

Get Your FREE Presidential Transition Guide Today
6/30/202118,800 shares $59,784.00 +37.2%0.2%0.2 $3.18
6/15/202113,700 shares $39,045.00 -2.8%0.2%0.2 $2.85
5/28/202114,100 shares $41,595.00 +30.6%0.2%0.2 $2.95
5/14/202110,800 shares $30,348.00 -90.7%0.1%0.1 $2.81
4/30/2021115,800 shares $431,934.00 -14.7%1.5%0.7 $3.73
4/15/2021135,800 shares $435,918.00 -64.8%1.7%0.7 $3.21
3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13
3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75
2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37
2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35
1/29/2021138,400 shares $546,693.84 +63.2%2.0%0.6 $3.95
1/15/202184,800 shares $367,184.00 No Change1.2%0.7 $4.33

INM Short Interest - Frequently Asked Questions

What is InMed Pharmaceuticals' current short interest?

Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 27,500 shares of INM short. 3.87% of InMed Pharmaceuticals' shares are currently sold short. Learn More on InMed Pharmaceuticals' current short interest.

What is a good short interest percentage for InMed Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.87% of InMed Pharmaceuticals' floating shares are currently sold short.

Is InMed Pharmaceuticals' short interest increasing or decreasing?

InMed Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 27,500 shares, an increase of 26.7% from the previous total of 21,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does InMed Pharmaceuticals' short interest compare to its competitors?

3.87% of InMed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Affimed (4.54%), MEI Pharma, Inc. (0.04%), Imunon, Inc. (8.63%), Sol-Gel Technologies Ltd. (0.14%), ABVC BioPharma, Inc. (2.56%), TherapeuticsMD, Inc. (1.49%), Marker Therapeutics, Inc. (5.35%), Incannex Healthcare Inc. (0.33%), Moleculin Biotech, Inc. (4.08%), Rallybio Co. (1.69%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short InMed Pharmaceuticals stock?

Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against InMed Pharmaceuticals?

A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further.

How often is InMed Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:INM) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners